e l f Beauty Inc vs Philip Morris International Inc. — how do they compare? e l f Beauty Inc trades at $74.75 (market cap $4.37B), while Philip Morris International Inc. trades at $185.88 (market cap $281.91B). The key difference: Philip Morris International Inc. is far larger — about 64.5× e l f Beauty Inc's market cap, and Philip Morris International Inc. pays a 3.25% dividend while e l f Beauty Inc pays none. Which is the better fit depends on your goals.
| ELF | PM | |
|---|---|---|
Market Cap | $4.37B | $281.91B |
Sector | Technology | Consumer Staples |
52-Week High | $146.67 | $191.86 |
52-Week Low | $49.57 | $144.33 |
Enterprise Value | $5.00B | $328.41B |
Dividend Yield | — | 3.25% |
Signals from Pluang's Aura AI — not financial advice
ELF Beauty trades at $76.11, up 5.34% with bullish technical signals and strong earnings beats. The stock shows robust revenue growth reaching $1.31B in 2025, though net margins remain thin at 1.61%. Recent analyst coverage is mixed with 46% buy ratings and consensus target of $74.42, slightly below current price. The company demonstrates solid operational cash flow of $133.84M and maintains a healthy balance sheet with $148.69M cash.
Outlook remains positive with continued double-digit sales growth targets, though elevated P/E ratio of 168.68 presents valuation concerns. Key risks include tariff exposure and core brand momentum challenges. Institutional sentiment leans bullish with recent price momentum supported by earnings outperformance and strategic expansion into skincare categories.
No Aura AI signal available yet.
Trailing returns across standard periods
e.l.f. Beauty is a leading cosmetics company offering high-quality, 100% vegan, and cruelty-free products. It is known for its affordable and prestige-quality makeup and skincare items for a diverse global audience.
Read more on ELF →Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →